期刊文献+

不同铁螯合剂治疗输血依赖性铁过载的对比研究

A comparative study of different iron chelation therapy transfusion dependent iron overload
下载PDF
导出
摘要 目的:对比不同铁螯合剂对贫血患者长期输血治疗后铁过载的驱铁作用及安全性.方法:将24例反复输血的患者在血清铁蛋白(SF)水平相同条件下随机均分为三组,采用不同铁螯合剂去铁治疗,分别检测其在治疗后1个月、2个月、3个月的铁蛋白(SF)水平,并观察其治疗相关不良反应.结果:地拉罗司组在治疗后SF下降最明显,且不良反应最少.结论:地拉罗司治疗输血依赖性铁过载的效果最好,安全性较高,不良反应最少. AIM: To compare the effects and safety of iron overload of patients with anemia who received different iron chelators treatment after long-term transfusion. METHODS: Dividing the 24 patients who transfused blood repeatedly into three groups un- der the same condition of serum ferritin (SF) level for iron removal treatment with different iron chelators. Then we detected the serum ferritin (SF) level after treatment of lmonth, 2 months and 3 months respectively, and observed the adverse reactions relatively. RESULTS: The group with Deferasirox that the SF level decreased at most and had minimal adverse reactions after treatment. CONCLUSION: The best therapeutic efficacy for iron overload of transfusion dependency is Deferasirox which has high safety and minimal adverse reactions.
出处 《转化医学电子杂志》 2014年第3期107-108,共2页 E-Journal of Translational Medicine
关键词 铁螯合剂 治疗 输血依赖 铁过载 iron chelator therapy transfusion dependency iron overload
  • 相关文献

参考文献11

  • 1Gattermann N. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload[J].Leu-kem Res,2007.S10-S15.
  • 2Cappellini MD,Porter J,El-Beshlawy A. Tailoring iron chela-tion by iron intake and serum ferritin:the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias[J].HAEMATOLOGICA,2010,(04):557-566.
  • 3黄永兰,刘莎,夏婷,郝文革,梁薇,孙新.重型β-地中海贫血患儿生长发育异常及其与铁超负荷的关系[J].中国当代儿科杂志,2008,10(5):603-606. 被引量:16
  • 4Goldberg S L,Chen E,Corral M. Incidence and clinical com-plications of myelodysplastic syndromes among United States Medi-care beneficiaries[J].Journal of Clinical Oncology,2010,(17):2847-2852.
  • 5Galaris D,Mantzaris M,Amorgianiotis C. Oxidative stress and ag-ing:the potential role of iron[J].Hormones,2008,(02):114-122.
  • 6Tuomainen TP,Loft S,Nyyssnen K. Body iron is a contribu-tor to oxidative damage of DNA[J].Free Radical Research,2007,(03):324-328.
  • 7Weinberg ED. Iron availability and infection[J].Biochimica et Biophysica Acta,2009,(07):600-605.
  • 8Cooksey RC,Jones D,Gabrielsen S. Dietary iron restriction or iron chelation protects from diabetes and loss ofβ-cell function in the obese (ob/ob lep-/-)mouse[J].American Journal of Physiology Endocrinology and Metabolism,2010,(06):E1236.
  • 9Waldmeier FJ,Bruin GJ,Glaenzel U. Pharmacokinetics,me-tabolism and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state[J].DRUG METABOLISM AND DISPOSITION,2010,(05):808-816.
  • 10Pennell DJ,Porter JB,Cappellini MD. Continued improve-ment in myocardial T2* over two years of deferasirox therapy in b-thalassemia major patients with cardiac iron overload[J].Haemato-logica,2011,(01):48-54.

二级参考文献6

  • 1Dundar U, Kupesiz U, Ozdem S, Gilgil E, Tuncer T, Yesilipek A. Bone metabolism and mineral density in patients with beta-thalassemia major[J]. Saudi Med J, 2007, 28(9) :1425-1429.
  • 2De Sanctis V, Eleftherion A, Malaventura C. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation ( TIF ) [ J ]. Pediatr Endocrinol Rev, 2004 ( Suppl 2 ) : 249- 255.
  • 3Moayeri H, Oloomi Z. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in betathalassemia major[ J ]. Arch Iran Med, 2006, 9 (4) :329-334.
  • 4De Simone M, Verrotti A, Iughetti L, Palumbo M, Di Bartolomeo P, Olioso P, et al. Final height of thalassemic patients who underwent bone marroW transplantation during childhood[ J]. Bone Marrow Transplant, 2001, 28 (2) :201-205.
  • 5De Sanctis V. Growth and puberty and its management in thalassaemia[J]. Hor Res, 2002, 58(Suppl 1) :72-79.
  • 6Christoforidis A, Haritandi A, Perifanis V, Tsatra I, Athanassiou- Metaxa M, Dimitriadis AS. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major[J]. Eur J Radiol, 2007, 62(1) :138-142.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部